The Journal
Impact factor: 5.483
5-Yr impact factor: 6.043
Also affiliated with
For Authors
Alerting Services
Corporate Services
Most
-
Most Read
- Symptoms and problems in the end-of-life phase of high-grade glioma patients
- MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity
- Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
- The treatment of malignant brain tumors in infants and very youngchildren: An update of the Pediatric Oncology Group experience
- Abstracts from the Thirteenth International Symposium on Pediatric Neuro-Oncology
-
Most Cited
- Epidemiology of primary brain tumors: Current concepts and review of theliterature
- Primary and secondary glioblastomas: From concept to clinicaldiagnosis
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- Patient tumor EGFR and PDGFRA gene amplificationsretained in an invasive intracranial xenograft model of glioblastomamultiforme
- A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma